Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,264 | 46,938 | 33,718 | 25,091 | 14,472 |
| Receivables | 1,086 | 12,120 | 14,859 | 13,120 | 14,394 |
| Inventories | N/A | N/A | N/A | 0 | 543 |
| TOTAL | $26,453 | $59,581 | $49,450 | $39,244 | $30,679 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 4,157 | 10,376 | 15,052 |
| Investments And Advances | N/A | N/A | 0 | 59 | 265 |
| Other Non-Current Assets | 146 | 589 | 1,208 | 0 | 14 |
| TOTAL | $146 | $589 | $5,365 | $10,435 | $15,331 |
| Total Assets | $26,599 | $60,170 | $54,815 | $49,679 | $46,010 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 333 |
| Accounts payable and accrued liabilities | 433 | 5,146 | 5,389 | 6,235 | 8,155 |
| TOTAL | $451 | $13,347 | $13,787 | $7,463 | $12,103 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 121 | 71 | 502 | 569 | 0 |
| TOTAL | $121 | $71 | $502 | $1,225 | $1,346 |
| Total Liabilities | $572 | $13,418 | $14,289 | $8,688 | $13,449 |
| Shareholders' Equity | |||||
| Common Shares | 21,304 | 19,786 | 39,772 | 44,201 | 0 |
| Retained earnings | 4,207 | 9,665 | 112 | -4,148 | -11,695 |
| Other shareholders' equity | 8 | 0 | -20 | -21 | 19 |
| TOTAL | $26,027 | $46,752 | $40,526 | $40,991 | $32,561 |
| Total Liabilities And Equity | $26,599 | $60,170 | $54,815 | $49,679 | $46,010 |